tirzepatide approved for sleep apnea GLP-1 medication is known to improve apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor of medicine at Brigham and FDA Approves Tirzepatide (Zepbound) as

H.FrydlandM.Winther-JensenM.et al (2018)

Sources FDA FDA Approves New Medication for Chronic Weight Management FDA Wegovy Prescribing Information New England Journal of Medicine Once-Weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Tirzepatide Once Weekly for the Treatment of Obesity CDC Adult Obesity Facts NIDDK Definition & Facts for Adult Overweight & Obesity World Health Organization Obesity: GLP-1 Therapies

But surrounding this core is the ischemic penumbra, a larger region of at-risk tissue that is damaged but not yet dead

How Is Semaglutide Administered Semaglutide is a liquid that is injected under the skin weekly

Tirzepatide did not increase the odds of hypoglycaemia but was associated with increased incidence of gastrointestinal adverse events